Your session is about to expire
← Back to Search
MRI + Biomarker Analysis for Identifying High-Risk Individuals Among Healthy Subjects
Study Summary
This trial is testing if using breast tissue markers in combination with MRI can more accurately assess a woman's risk of developing breast cancer.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing to donate any leftover tissue from my breast biopsy or surgery.I am willing to donate leftover tissue from my breast biopsy or surgery.I have an active cancer diagnosis, except for certain skin cancers and early breast changes.I haven't had chemotherapy in the last year before my breast MRI screening.I had breast radiation less than a year ago before my screening MRI.I have received radiation therapy to both of my breasts.I am getting a breast MRI because I'm at high risk for breast cancer.I am willing to have approximately 40 mL of blood drawn.I have had hormone therapy for breast cancer within the last year.I was previously diagnosed with stage 4 cancer.
- Group 1: Treatment (breast MRI, biopsy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In which geographic areas is this trial being conducted?
"This clinical trial is currently operating at 5 sites, including the University of Wisconsin in Madison, Ohio State University and Stefanie Spielman Comprehensive Breast Center in Columbus. Other participating locations include Duke University in Durham."
How many participants are taking part in this research study?
"The trial necessitates 650 participants, meeting the pre-set inclusion criteria. These individuals can register at either University of Wisconsin in Madison or Ohio State University’s Stefanie Spielman Comprehensive Breast Center in Columbus."
Are researchers looking to recruit more participants for this experiment?
"Affirmative. According to the information hosted on clinicaltrials.gov, this research study is actively recruiting and was first posted in October of 2017. 650 patients are needed at 5 different sites for successful completion of the trial."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger